Science & Enterprise subscription

Follow us on Twitter

  • A company developing a system with artificial intelligence to analyze medical literature for treatment insights is… https://t.co/TdK2vtumZo
    about 11 hours ago
  • New post on Science and Enterprise: Medical Knowledge A.I. Company Raises Early $4.8M https://t.co/lqYHuWQs7g #Science #Business
    about 11 hours ago
  • New contributed post on Science and Enterprise: https://t.co/3Gofb2uiDv Guidelines for Training New Employees
    about 14 hours ago
  • Regenstrief Institute, affiliated with Indiana University, is investing in a new company aiming to improve long-ter… https://t.co/87KTKEoWp8
    about 15 hours ago
  • New post on Science and Enterprise: Institute Invests in Elderly Care Start-Up https://t.co/mCNnAqV9yY #Science #Business
    about 15 hours ago

Please share Science & Enterprise

FDA Tags Biofilm Disruption Device as Breakthrough

MRSA bacteria

A system using an electric current to break up bacterial communities on orthopedic implants received a breakthrough-device designation from the Food and Drug Administration. . . . → Read More: FDA Tags Biofilm Disruption Device as Breakthrough

Trial Shows Nanotech Drug Induces Gluten Tolerance

bread and rolls

Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease. . . . → Read More: Trial Shows Nanotech Drug Induces Gluten Tolerance

Merck Gaining Gut Microbe Technology for Vaccines

Microbiome graphic

Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines

Biotech Developing Genome-Adjusting Disease Treatments

DNA analysis graphic

A new biotechnology enterprise is creating disease treatments that address regions in the genome precisely regulating expression of proteins. . . . → Read More: Biotech Developing Genome-Adjusting Disease Treatments

Start-Up Targets Extra DNA in Cancer, Raises $46.4M

Paul Mischel

A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes. . . . → Read More: Start-Up Targets Extra DNA in Cancer, Raises $46.4M

Spin-Off Licensing Athletic Microbiome Technology

Runners

A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics. . . . → Read More: Spin-Off Licensing Athletic Microbiome Technology

Infographic – IBM Leads Again in Patent Awards

Chart: patents awarded in 2018

Statista prepared a chart this week with data from an annual report by the Intellectual Property Owners Association, this weekend’s infographic on Science & Enterprise. . . . → Read More: Infographic – IBM Leads Again in Patent Awards

Company Forms to Treat Vaginal Microbial Disorders

Lactobacillus

A new enterprise has launched to develop live microbial treatments for urinary tract infections and other diseases originating in vaginal bacterial communities. . . . → Read More: Company Forms to Treat Vaginal Microbial Disorders

A.I. Helps Visualize Emergency Social Media Data

Helping flooded regions

A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially catastrophic events in real time by analyzing text and images on social media. . . . → Read More: A.I. Helps Visualize Emergency Social Media Data

Hearing Loss Cell Therapy Licensed in $625M Deal

Man with headphones

A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal